
Researchers from CUSAT and SCTIMST found significant differences in gut microbiome composition between Parkinson's disease patients and healthy individuals.
The study analyzed stool samples from 65 patients and 65 healthy spouses using metagenomic sequencing, identifying elevated inflammation-linked bacteria.
Funded by the ICMR, the findings suggest gut microbial shifts influence neurotransmitters like dopamine and could aid in early diagnostic tests.